Immunomedics' pancreatic cancer test also predicts responders
This article was originally published in Clinica
Executive Summary
A pancreatic cancer test kit being developed by Immunomedics not only diagnoses the disease, but could also help identify which patients are responding to the firm's experimental treatment.